Skip to content

S. 1041 · 119th Congress (2025–2027)

Affordable Prescriptions for Patients Act

This bill limits in certain instances the number of patents that the manufacturer of a biologic drug can assert in a lawsuit against a company seeking to sell a biosimilar version of that drug. (A biologic drug is produced through natural processes or isolated from natural sources. A biosimilar version is substantially similar to the original biologic, which is the reference product, and is often marketed as a less expensive alternative.)

The bill's provisions apply to an existing framework that gives the biosimilar manufacturer an abbreviated path to Food and Drug Administration approval to sell the biosimilar. Specifically, if the biosimilar manufacturer completes certain actions under the framework, such as sharing certain information about its product with the reference product manufacturer, the bill limits the number of certain patents that the reference product manufacturer may assert in a lawsuit, such as patents that were filed more than four years after the reference product received market approval. The limit shall not apply to patents claiming certain methods for using the biologic drug.

The court in which the infringement lawsuit is filed may increase the limit if justice so requires or if there is good cause for the increase.

Show official title

A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes.

Passed Senate

This bill’s path

495 days after it was introduced

This is S. 1041’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced16 months

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

Sponsor
Sen. John Cornyn (R-TX)
Cosponsors
3 cosponsors

3 original · 0 later

  1. Sen. Richard Blumenthal (D-CT)· Original · Mar 13, 2025
  2. Sen. Richard J. Durbin (D-IL)· Original · Mar 13, 2025
  3. Sen. Chuck Grassley (R-IA)· Original · Mar 13, 2025
Policy area
Commerce
Subjects
  • Civil actions and liability
  • Competition and antitrust
  • Consumer affairs
  • Drug safety, medical device, and laboratory regulation
  • Health care costs and insurance
  • Inflation and prices
  • Intellectual property
  • Judicial review and appeals
  • 2 more
    • Manufacturing
    • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. ▸ 3 committee actions · Mar 13, 2025 – Apr 10, 2025
    1. Referred to committee

      Read twice and referred to the Committee on the Judiciary.

      Sources
    2. Ordered reported

      Committee on the Judiciary. Ordered to be reported with amendments favorably.

      Sources
    3. Reported by committee

      Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.

      Sources
  3. Latest

    Passed Senate

    Congressional Record S4198-4199; text: CR S4199

    Passed Senate with amendments by Unanimous Consent.

    The Senate passed the bill.

    Document: Engrossed in Senate

    Sources

Committees

  1. SenateJudiciaryReferred Mar 13, 2025 · Markup Apr 3, 2025 · Reported Apr 10, 2025
    1. Apr 3, 2025 · Meeting

Floor record

i

Explicit consideration evidence: the measure’s bill-status citation matched a GovInfo title, headline, or first paragraph. Incidental mentions are not listed.

  1. Jul 21, 2026 · Senate · Passed Senate with amendments by Unanimous ConsentCongressional Record S4198–S4199

    Affordable Prescriptions for Patients Act

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Reported to Senate
Engrossed in Senate
Titles (2)
  1. Affordable Prescriptions for Patients Act

    Display title, Short title · Engrossed in Senate, Reported to Senate, Introduced in Senate

  2. A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes.

    Official title · Introduced in Senate